[Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes
Farmacia Hospitalaria · 2026-11 · 50 (6) · T397-T405
DOI: 10.1016/j.farma.2026.07.006 ↗Kurz gefasst
Leitlinie in der Zeitschrift Farmacia Hospitalaria, 2026-11. Verfasst von Inmaculada Romero-Zayas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Radiofarmacia, Servicio de Medicina Nuclear, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain. Electronic address: icromero@clinic.c…. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Leukocytes, Isotope Labeling. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This guide outlines the radiopharmaceutical procedure for the in vitro labelling of leukocytes. Scintigraphy using leukocytes labeled with [99mTc]Tc-exametazime or [111In]In-oxine is a highly valuable diagnostic tool in infectious and inflammatory diseases due to its high sensitivity and specificity. It is based on established guidelines and consensus protocols, which incorporate the recent Spanish regulations on the extemporaneous preparation of radiopharmaceuticals, this document provides detailed and precise instructions for the safe and effective preparation and quality control of in vitro labeled leukocytes. The clinical indications for leukocyte scintigraphy are described, along with the technical requirements for both facilities and equipment. The various stages of the radiolabelling procedure are developed and substantiated, including blood sample collection, leukocyte fraction separation and isolation, incubation and subsequent radiolabelling with either [99mTc]Tc-exametazime or [111In]In-oxine, radiopharmaceutical conditioning for administration, and the necessary quality control procedures. The document concludes with a section describing drug interactions reported in the literature. Two annexes are included, providing example labeling protocols for both radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Radiofarmacia, Servicio de Medicina Nuclear, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain. Electronic address: icromero@clinic.cat.
- Unidad de Radiofarmacia, Hospital Universitario Marqués de Valdecilla, Grupo de Imagen Molecular IDIVAL Santander, Spain.
- Unidad de Radiofarmacia, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Unidad de Radiofarmacia, Hospital Universitario La Paz, Madrid, Spain.
- Unidad de Radiofarmacia, Hospital Universitario Doctor Peset, Valencia, Spain.
- Servicio de Farmacia, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
Zitieren
APA
Romero-Zayas, I., de Arcocha-Torres, M., Peñuelas, I., Martínez Montalbán, E., Plancha Mansanet, M. C., Fernández Sánchez, A. J., & Pérez Iruela, J. A. (2026). [Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes. Farmacia Hospitalaria, 50(6), T397-T405. https://doi.org/10.1016/j.farma.2026.07.006
Vancouver
Romero-Zayas I, de Arcocha-Torres M, Peñuelas I, Martínez Montalbán E, Plancha Mansanet MC, Fernández Sánchez AJ, et al. [Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes. Farmacia Hospitalaria. 2026;50(6):T397-T405. doi:10.1016/j.farma.2026.07.006
BibTeX
@article{RomeroZayas2026,
author = {Romero-Zayas, Inmaculada and de Arcocha-Torres, María and Peñuelas, Iván and Martínez Montalbán, Elena and Plancha Mansanet, María Carmen and Fernández Sánchez, Antonio de Jesús and Pérez Iruela, Juan Antonio},
title = {[Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes},
journal = {Farmacia Hospitalaria},
year = {2026},
volume = {50},
number = {6},
pages = {T397--T405},
doi = {10.1016/j.farma.2026.07.006}
}
EUVIMED